Clear Value

Wealth Management Solution

Fintech & Insurtech
Non Active, Jan 2023 ceased to operate
Pre-Seed Israel Founded 2019
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Seed
Founded
2019
Headcount
3
HQ
Israel
Sector
Fintech & Insurtech

About

Clear Value is the developer of Claritus, a B2C personal wealth service that provides a precise, up-to-the-minute view of all the user's assets in one convenient, easy-to-use solution. It provides a simple way for users to track, understand, and make better-informed decisions regarding their wealth.

Q&A

What is Clear Value's primary business?
Clear Value develops Claritus, a B2C personal wealth service that offers users a precise, up-to-the-minute view of all their assets in a single solution, enabling them to track, understand, and make informed decisions about their wealth.
What is the current status of Clear Value?
Clear Value is currently inactive, having ceased operations in January 2023.
When was Clear Value founded?
Clear Value was founded in August 2019.
How many employees does Clear Value have?
Clear Value has 1-10 employees.
In which sector does Clear Value primarily operate?
Clear Value's primary sector is Fintech & Insurtech.
What business model does Clear Value use?
Clear Value operates with a B2C (Business-to-Consumer) business model.
What is Clear Value's current funding stage?
Clear Value is in the Pre-Seed funding stage.

Team · 3

Founder · Co-founder & Chairman
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Fintech & Insurtech
Sub-sectors
Fintech & InsurtechPersonal Finance ManagementTrading & Investing
Technologies
Platforms & InterfacesWebArtificial IntelligenceData StorageCDN
Target customers
Financial ServicesInvestment & Portfolio ManagementFund ManagementCustodianFinancial InstitutionsBanksConsumers
Business model
B2C

Highlights

Verified

Tags

private-investorsinvestmentspersonal-financefintech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)